Adecatumumab
From Self-sufficiency
Revision as of 23:01, 31 May 2010 by Citation bot 1 (Talk) (Citations: [Pu155]+: pmc. You can use this bot yourself! Report bugs here.)
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Template:Infobox drug/mab source |
| Target | EpCAM |
| Identifiers | |
| CAS Number | 503605-66-1 |
| ATC code | none |
| Chemical data | |
| Formula | C6552H10080N1740O2052S46 |
| Molar mass | 147.5 kDa[[Script error: No such module "String".]] |
Adecatumumab (MT201) is a recombinant human monoclonal antibody which is used to target tumor cells. It binds to the epithelial cell adhesion molecule (EpCAM - CD326).
Adecatumumab has been used in clinical studies of treatment in prostate[1] and breast cancers[2].
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Chemotherapeutic agents
- Pages with broken file links
- Monoclonal antibody stubs
